Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans

Biological Psychiatry

Volumn 73, Issue 4, 2013, Pages 337-344

  Leicht, Gregor ^a,b   Mulert, Christoph ^a,b   Eser, Daniela ^b   Sämann, Philipp G ^d   Ertl, Matthias ^a,b   Laenger, Anna ^b   Karch, Susanne ^b   Pogarell, Oliver ^b   Meindl, Thomas ^c   Czisch, Michael ^d   Rupprecht, Rainer ^b,e  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

ACC; alprazolam; anxiety; benzodiazepine; CCK 4; fMRI

Indexed keywords

ALPRAZOLAM; TETRAGASTRIN;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANXIETY; ARTICLE; ATTENUATION; BEHAVIOR; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; DOSE RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; NEUROIMAGING; NORMAL HUMAN; PANIC; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROVOCATION TEST; TREATMENT RESPONSE;

ADULT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANXIETY; BRAIN; BRAIN MAPPING; DOUBLE-BLIND METHOD; GABA MODULATORS; GYRUS CINGULI; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; TETRAGASTRIN;

EID: 84872869945     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.09.004     Document Type: Article

References (59)

1. M. Lader Benzodiazepines revisited - will we ever learn? Addiction 106 2011 2086 2109
2. H. Mohler, J.M. Fritschy, and U. Rudolph A new benzodiazepine pharmacology J Pharmacol Exp Ther 300 2002 2 8
3. R. Rupprecht, G. Rammes, D. Eser, T.C. Baghai, C. Schule, and C. Nothdurfter Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects Science 325 2009 490 493
4. E. Maron, I. Toru, G. Tasa, A. Must, E. Toover, and A. Lang Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers Neurosci Lett 446 2008 88 92
5. A. Strohle, E. Romeo, F. di Michele, A. Pasini, B. Hermann, and G. Gajewsky Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder: Preliminary results Arch Gen Psychiatry 60 2003 161 168
6. N. Singewald, and T. Sharp Neuroanatomical targets of anxiogenic drugs in the hindbrain as revealed by Fos immunocytochemistry Neuroscience 98 2000 759 770
7. J. Bradwejn, D. Koszycki, and G. Meterissian Cholecystokinin-tetrapeptide induces panic attacks in patients with panic disorder Can J Psychiatry 35 1990 83 85
8. J. Bradwejn, D. Koszycki, and C. Shriqui Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings Arch Gen Psychiatry 48 1991 603 610
9. J. Bradwejn, and D. Koszycki Cholecystokinin and panic disorder: Past and future clinical research strategies Scand J Clin Lab Invest Suppl 234 2001 19 27
10. D. Eser, G. Leicht, J. Lutz, S. Wenninger, V. Kirsch, and C. Schule Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers Hum Brain Mapp 30 2009 511 522
11. D. Eser, C. Schule, T. Baghai, A. Floesser, A. Krebs-Brown, and M. Enunwa Evaluation of the CCK-4 model as a challenge paradigm in a population of healthy volunteers within a proof-of-concept study Psychopharmacology (Berl) 192 2007 479 487
12. J. Bradwejn, D. Koszycki, A. Couetoux du Tertre, H. van Megen, J. den Boer, and H. Westenberg The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder Arch Gen Psychiatry 51 1994 486 493
13. A.C. Dieler, P.G. Samann, G. Leicht, D. Eser, V. Kirsch, and T.C. Baghai Independent component analysis applied to pharmacological magnetic resonance imaging (phMRI): New insights into the functional networks underlying panic attacks as induced by CCK-4 Curr Pharm Des 14 2008 3492 3507
14. T. Schunck, G. Erb, A. Mathis, C. Gilles, I.J. Namer, and Y. Hode Functional magnetic resonance imaging characterization of CCK-4-induced panic attack and subsequent anticipatory anxiety Neuroimage 31 2006 1197 1208
15. T. Schunck, A. Mathis, G. Erb, I.J. Namer, Y. Hode, and A. Demazieres One milligram of lorazepam does not decrease anxiety induced by CCK-4 in healthy volunteers: Investigation of neural correlates with BOLD MRI J Psychopharmacol 25 2011 52 59
16. J.M. Le Melledo, S. Merani, D. Koszycki, F. Bellavance, R. Palmour, and J. Gutkowska Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases Neuropsychopharmacology 20 1999 81 91
17. J.M. Le Melledo, J. Bradwejn, D. Koszycki, and D. Bichet Premenstrual dysphoric disorder and response to cholecystokinin-tetrapeptide Arch Gen Psychiatry 52 1995 605 606
18. J.M. Le Melledo, H. Arthur, J. Dalton, C. Woo, N. Lipton, and F. Bellavance The influence of Type A behavior pattern on the response to the panicogenic agent CCK-4 J Psychosom Res 51 2001 513 520
19. D. Eser, G. Leicht, T. Baghai, O. Pogarell, C. Schule, and S. Karch Impact of loudness dependency of auditory evoked potentials on the panic response to CCK-4 J Psychiatr Res 43 2009 393 400
20. D. Eser, M. Uhr, G. Leicht, M. Asmus, A. Langer, and C. Schule Glyoxalase-I mRNA expression and CCK-4 induced panic attacks J Psychiatr Res 45 2011 60 63
21. A.J. Flint, D. Koszycki, F.J. Vaccarino, A. Cadieux, J.P. Boulenger, and J. Bradwejn Effect of aging on cholecystokinin-induced panic Am J Psychiatry 155 1998 283 285
22. M. McKeown, Y.J. Hu, and Z. Jane Wang ICA denoising for event-related fMRI studies Conf Proc IEEE Eng Med Biol Soc 1 2005 157 161
23. C.G. Thomas, R.A. Harshman, and R.S. Menon Noise reduction in BOLD-based fMRI using component analysis Neuroimage 17 2002 1521 1537
24. Minka T (2000): Automatic choice of dimensionality for PCA. Cambridge: Massachusetts Institute of Technology. Technical Report #514
25. A. Hyvarinen Fast and robust fixed-point algorithms for independent component analysis IEEE Trans Neural Netw 10 1999 626 634
26. S.D. Forman, J.D. Cohen, M. Fitzgerald, W.F. Eddy, M.A. Mintun, and D.C. Noll Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): Use of a cluster-size threshold Magn Reson Med 33 1995 636 647
27. R. Goebel, F. Esposito, and E. Formisano Analysis of functional image analysis contest (FIAC) data with brainvoyager QX: From single-subject to cortically aligned group general linear model analysis and self-organizing group independent component analysis Hum Brain Mapp 27 2006 392 401
28. L.M. McCormick, S. Ziebell, P. Nopoulos, M. Cassell, N.C. Andreasen, and M. Brumm Anterior cingulate cortex: An MRI-based parcellation method Neuroimage 32 2006 1167 1175
29. J.C. Ballenger, G.D. Burrows, R.L. DuPont Jr, I.M. Lesser, R. Noyes Jr, and J.C. Pecknold Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial. I. Efficacy in short-term treatment Arch Gen Psychiatry 45 1988 413 422
30. P. Zwanzger, D. Eser, S. Aicher, C. Schule, T.C. Baghai, and F. Padberg Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: A placebo-controlled study Neuropsychopharmacology 28 2003 979 984
31. P. Zwanzger, T.C. Baghai, C. Schuele, A. Strohle, F. Padberg, and N. Kathmann Vigabatrin decreases cholecystokinin-tetrapeptide (CCK-4) induced panic in healthy volunteers Neuropsychopharmacology 25 2001 699 703
32. P. Zwanzger, D. Eser, F. Padberg, T.C. Baghai, C. Schule, and F. Rotzer Effects of tiagabine on cholecystokinin-tetrapeptide (CCK-4)-induced anxiety in healthy volunteers Depress Anxiety 18 2003 140 143
33. B. Pfleiderer, S. Zinkirciran, V. Arolt, W. Heindel, J. Deckert, and K. Domschke fMRI amygdala activation during a spontaneous panic attack in a patient with panic disorder World J Biol Psychiatry 8 2007 269 272
34. Y. Sakai, H. Kumano, M. Nishikawa, Y. Sakano, H. Kaiya, and E. Imabayashi Cerebral glucose metabolism associated with a fear network in panic disorder Neuroreport 16 2005 927 931
35. A. Bystritsky, D. Pontillo, M. Powers, F.W. Sabb, M.G. Craske, and S.Y. Bookheimer Functional MRI changes during panic anticipation and imagery exposure Neuroreport 12 2001 3953 3957
36. M.L. Boshuisen, G.J. Ter Horst, A.M. Paans, A.A. Reinders, and J.A. den Boer rCBF differences between panic disorder patients and control subjects during anticipatory anxiety and rest Biol Psychiatry 52 2002 126 135
37. C. Benkelfat, J. Bradwejn, E. Meyer, M. Ellenbogen, S. Milot, and A. Gjedde Functional neuroanatomy of CCK4-induced anxiety in normal healthy volunteers Am J Psychiatry 152 1995 1180 1184
38. M. Javanmard, J. Shlik, S.H. Kennedy, F.J. Vaccarino, S. Houle, and J. Bradwejn Neuroanatomic correlates of CCK-4-induced panic attacks in healthy humans: A comparison of two time points Biol Psychiatry 45 1999 872 882
39. R. Garcia, R.M. Vouimba, M. Baudry, and R.F. Thompson The amygdala modulates prefrontal cortex activity relative to conditioned fear Nature 402 1999 294 296
40. F. Sotres-Bayon, D.E. Bush, and J.E. LeDoux Emotional perseveration: An update on prefrontal-amygdala interactions in fear extinction Learn Mem 11 2004 525 535
41. A. Etkin, T. Egner, D.M. Peraza, E.R. Kandel, and J. Hirsch Resolving emotional conflict: A role for the rostral anterior cingulate cortex in modulating activity in the amygdala Neuron 51 2006 871 882
42. D. Mobbs, J.L. Marchant, D. Hassabis, B. Seymour, G. Tan, and M. Gray From threat to fear: The neural organization of defensive fear systems in humans J Neurosci 29 2009 12236 12243
43. L. Pezawas, A. Meyer-Lindenberg, E.M. Drabant, B.A. Verchinski, K.E. Munoz, and B.S. Kolachana 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: A genetic susceptibility mechanism for depression Nat Neurosci 8 2005 828 834
44. M.R. Delgado, K.I. Nearing, J.E. Ledoux, and E.A. Phelps Neural circuitry underlying the regulation of conditioned fear and its relation to extinction Neuron 59 2008 829 838
45. H.T. Ghashghaei, and H. Barbas Pathways for emotion: Interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey Neuroscience 115 2002 1261 1279
46. D.G. Amaral The primate amygdala and the neurobiology of social behavior: Implications for understanding social anxiety Biol Psychiatry 51 2002 11 17
47. V.S. Fenelon, and A.E. Herbison Plasticity in GABAA receptor subunit mRNA expression by hypothalamic magnocellular neurons in the adult rat J Neurosci 16 1996 4872 4880
48. V.S. Fenelon, and A.E. Herbison In vivo regulation of specific GABAA receptor subunit messenger RNAs by increased GABA concentrations in rat brain Neuroscience 71 1996 661 670
49. J.M. Fritschy, O. Weinmann, A. Wenzel, and D. Benke Synapse-specific localization of NMDA and GABA(A) receptor subunits revealed by antigen-retrieval immunohistochemistry J Comp Neurol 390 1998 194 210
50. Z. Nusser, W. Sieghart, D. Benke, J.M. Fritschy, and P. Somogyi Differential synaptic localization of two major gamma-aminobutyric acid type A receptor alpha subunits on hippocampal pyramidal cells Proc Natl Acad Sci U S A 93 1996 11939 11944
51. R.M. McKernan, and P.J. Whiting Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19 1996 139 143
52. S. Pirker, C. Schwarzer, A. Wieselthaler, W. Sieghart, and G. Sperk GABA(A) receptors: Immunocytochemical distribution of 13 subunits in the adult rat brain Neuroscience 101 2000 815 850
53. U. Rudolph, and H. Mohler GABA-based therapeutic approaches: GABAA receptor subtype functions Curr Opin Pharmacol 6 2006 18 23
54. C.M. Del-Ben, C.A. Ferreira, T.A. Sanchez, W.C. Alves-Neto, V.G. Guapo, and D.B. de Araujo Effects of diazepam on BOLD activation during the processing of aversive faces J Psychopharmacol 26 2012 443 451
55. M.P. Paulus, J.S. Feinstein, G. Castillo, A.N. Simmons, and M.B. Stein Dose-dependent decrease of activation in bilateral amygdala and insula by lorazepam during emotion processing Arch Gen Psychiatry 62 2005 282 288
56. T. Schunck, A. Mathis, G. Erb, I.J. Namer, A. Demazieres, and R. Luthringer Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge J Psychopharmacol 24 2010 701 708
57. J. Bradwejn, and D. Koszycki The cholecystokinin hypothesis of anxiety and panic disorder Ann N Y Acad Sci 713 1994 273 282
58. R.M. Birn, K. Murphy, and P.A. Bandettini The effect of respiration variations on independent component analysis results of resting state functional connectivity Hum Brain Mapp 29 2008 740 750
59. R.M. Birn, K. Murphy, D.A. Handwerker, and P.A. Bandettini fMRI in the presence of task-correlated breathing variations Neuroimage 47 2009 1092 1104